Correction to: Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy

被引:0
|
作者
Eric Wenzler
David Butler
Xing Tan
Takayuki Katsube
Toshihiro Wajima
机构
[1] University of Illinois at Chicago,Department of Pharmacy Practice, College of Pharmacy
[2] Shionogi & Co.,Clinical Pharmacology and Pharmacokinetics
[3] Ltd.,Clinical Pharmacology
[4] IDEC Inc.,undefined
来源
Clinical Pharmacokinetics | 2022年 / 61卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1069 / 1069
相关论文
共 50 条
  • [1] Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy
    Wenzler, Eric
    Butler, David
    Tan, Xing
    Katsube, Takayuki
    Wajima, Toshihiro
    [J]. CLINICAL PHARMACOKINETICS, 2022, 61 (04) : 539 - 552
  • [2] Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy
    Eric Wenzler
    David Butler
    Xing Tan
    Takayuki Katsube
    Toshihiro Wajima
    [J]. Clinical Pharmacokinetics, 2022, 61 : 539 - 552
  • [3] Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy (vol 61, pg 539, 2022)
    Wenzler, Eric
    Butler, David
    Tan, Xing
    Katsube, Takayuki
    Wajima, Toshihiro
    [J]. CLINICAL PHARMACOKINETICS, 2022, 61 (07) : 1069 - 1069
  • [4] Dabigatran Pharmacokinetics and Pharmacodynamics during Renal Replacement Therapy
    Martin, Alison
    Tirona, Rommel
    Louise, Moist
    Lazo-Langner, Alejandro
    [J]. BLOOD, 2015, 126 (23)
  • [5] Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically Ill patients
    Fish, DN
    Teitelbaum, I
    Abraham, E
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (06) : 2421 - 2428
  • [6] Pharmacokinetics during continuous renal replacement therapy
    Keller, E
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1996, 19 (02): : 113 - 117
  • [7] Pharmacokinetics and pharmacodynamics in extracorporeal renal replacement therapy
    Kaechele, M.
    Keller, F.
    [J]. MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN, 2021, 116 (04) : 295 - 300
  • [8] EXTENDED-INFUSION CEFEPIME PHARMACOKINETICS/PHARMACODYNAMICS IN CONTINUOUS RENAL REPLACEMENT THERAPY
    Philpott, Carolyn
    Droege, Chris
    Healy, Daniel
    Droege, Molly
    Courter, Joshua
    Ernst, Neil
    Harger, Nicole
    Hillebrand, Kristen
    Winter, Jessica
    Foertsch, Madeline
    Athota, Krishna
    Mueller, Eric
    [J]. CRITICAL CARE MEDICINE, 2019, 47
  • [9] Cefiderocol Dosing for Patients Receiving Continuous Renal Replacement Therapy
    Wei, Xiaohui
    Naseer, Shabnam
    Weinstein, Edward A.
    Iarikov, Dmitri
    Nambiar, Sumathi
    Reynolds, Kellie S.
    Jang, Seong H.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (05) : 1004 - 1007
  • [10] Population pharmacokinetics/pharmacodynamics of linezolid in sepsis patients with and without continuous renal replacement therapy
    Ide, Takeshi
    Takesue, Yoshio
    Ikawa, Kazuro
    Morikawa, Norifumi
    Ueda, Takashi
    Takahashi, Yoshiko
    Nakajima, Kazuhiko
    Takeda, Kenta
    Nishi, Shinichi
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 51 (05) : 745 - 751